Unlocking the Power of Sorafenib Tosylate: A Targeted Therapy API by Yikang Chemical

Sorafenib tosylate, known by its CAS number 475207-59-1, is a powerful multikinase inhibitor primarily used in the treatment of advanced cancers such as hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), and differentiated thyroid carcinoma (DTC). As a highly active pharmaceutical ingredient (API), Sorafenib tosylate plays a vital role in targeted cancer therapy due to its dual-action mechanism of inhibiting tumor cell proliferation and angiogenesis. At Yikang Chemical (https://yikanghuagong.com/), we are committed to supplying top-grade Sorafenib tosylate with strict quality control and global regulatory compliance.

What Is Sorafenib Tosylate?

Sorafenib tosylate is the tosylate salt form of Sorafenib, a small molecule that blocks multiple intracellular and cell surface kinases, including RAF kinases, VEGFR, PDGFR, and c-KIT. This broad kinase inhibition allows it to interfere with tumor growth and vascularization, making it a key component in cancer therapeutics.

Chemical Details:

  • CAS Registry Number: 475207-59-1
  • Molecular Formula: C21H16ClF3N4O3 × C7H8O3S
  • Therapeutic Class: Anticancer agent, Kinase inhibitor
  • Common Brand Name: Nexavar

Key Medical Applications

Sorafenib tosylate is FDA-approved and widely used in clinical oncology to treat:

  • Hepatocellular Carcinoma (HCC): First-line treatment for unresectable liver cancer.
  • Renal Cell Carcinoma (RCC): Effective in advanced kidney cancer.
  • Differentiated Thyroid Carcinoma (DTC): Applied when radioactive iodine therapy fails.

Its wide-ranging efficacy in targeting tumor signaling pathways makes it a backbone in targeted molecular therapy.

Mechanism of Action

Sorafenib tosylate exerts its anticancer effects by:

  • Inhibiting RAF/MEK/ERK pathway, disrupting tumor cell division.
  • Blocking VEGFR and PDGFR, reducing tumor blood supply.
  • Suppressing receptor tyrosine kinases involved in tumor progression.

This multifaceted approach makes Sorafenib tosylate a valuable tool in precision oncology.

Yikang Chemical: Your Trusted Source for Sorafenib Tosylate

As a reliable API manufacturer and exporter, Yikang Chemical ensures:

  • High Purity Sorafenib Tosylate suitable for pharmaceutical formulation.
  • Strict GMP-compliant manufacturing environment.
  • Robust QC systems including HPLC, NMR, and MS for batch verification.
  • Global Supply Chain Support ensuring safe and timely delivery.

Keywords to Reach Us

To help clients discover us easily, we support global search with the following relevant terms:

  • Sorafenib tosylate supplier
  • Sorafenib CAS 475207-59-1 API manufacturer
  • Pharmaceutical grade Sorafenib for cancer treatment
  • Kinase inhibitor bulk powder
  • Nexavar intermediate source
  • Oncology raw material exporter
  • Sorafenib tosylate GMP certified factory

Let’s Partner for a Healthier Future

Yikang Chemical welcomes collaborations with pharmaceutical companies, research institutions, and distributors worldwide. For more details or inquiries about Sorafenib tosylate CAS 475207-59-1, visit us at: https://yikanghuagong.com/

Together, let’s advance the future of targeted cancer therapy.

Share this post
Facebook
Twitter
LinkedIn
WhatsApp